VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,152,791 | -54.9% | 123,030 | +18.1% | 0.00% | -66.7% |
| Q2 2023 | $2,554,750 | +12.7% | 104,148 | +7.0% | 0.00% | 0.0% |
| Q1 2023 | $2,266,009 | +18.4% | 97,379 | +28.7% | 0.00% | +50.0% |
| Q4 2022 | $1,914,524 | +490.9% | 75,643 | +350.5% | 0.00% | – |
| Q3 2022 | $324,000 | -34.3% | 16,791 | -13.3% | 0.00% | -100.0% |
| Q2 2022 | $493,000 | +17.9% | 19,372 | -5.7% | 0.00% | – |
| Q1 2022 | $418,000 | -4.6% | 20,545 | +96.2% | 0.00% | – |
| Q4 2021 | $438,000 | -1.1% | 10,472 | +2.8% | 0.00% | – |
| Q3 2021 | $443,000 | +6.2% | 10,188 | +15.6% | 0.00% | – |
| Q2 2021 | $417,000 | -4.6% | 8,811 | +3.5% | 0.00% | – |
| Q1 2021 | $437,000 | +90.8% | 8,515 | -0.2% | 0.00% | – |
| Q4 2020 | $229,000 | -32.6% | 8,536 | -13.8% | 0.00% | – |
| Q3 2020 | $340,000 | -6.8% | 9,898 | +11.0% | 0.00% | – |
| Q2 2020 | $365,000 | -24.3% | 8,921 | -36.6% | 0.00% | – |
| Q1 2020 | $482,000 | – | 14,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |